RA CAPITAL MANAGEMENT, L.P. Diversified Active

Location: Boston, MA

CIK: 0001346824 · Show all filings

Period: Q2 2019 (← Previous) (Next →)

Filing Date: Aug 14, 2019

Total Value: $1.863B (100.0% shares, 0.0% debt)

Holdings (25)

ASND ASCENDIS PHARMA A S 25.5%
Value $476M Shares 4,132,442 Share Price $115.15 Est. Cost/Share $17.96 Unrealized @ Report Date —
WVE WAVE LIFE SCIENCES LTD 10.9%
Value $203M Shares 7,775,207 Share Price $26.09 * Est. Cost/Share $17.26 Unrealized @ Report Date +62.5%
— ZOGENIX INC 9.5%
Value $178M Shares 3,722,504 Share Price $47.78 Est. Cost/Share $37.11 Unrealized @ Report Date —
— RA PHARMACEUTICALS INC 7.4%
Value $137M Shares 4,858,260 Share Price $28.19 Est. Cost/Share $8.41 Unrealized @ Report Date —
— SYNTHORX INC 7.1%
Value $131M Shares 9,724,598 Share Price $13.51 Est. Cost/Share $17.38 Unrealized @ Report Date —
— EIDOS THERAPEUTICS INC 6.1%
Value $113M Shares 2,162,671 Share Price $52.12 Est. Cost/Share $20.34 Unrealized @ Report Date —
— ORCHARD THERAPEUTICS PLC 3.8%
Value $71.47M Shares 5,108,330 Share Price $13.99 Est. Cost/Share $15.84 Unrealized @ Report Date —
TGTX TG THERAPEUTICS INC 3.2%
Value $59.52M Shares 6,880,323 Share Price $8.65 * Est. Cost/Share $12.35 Unrealized @ Report Date -38.8%
— MYOVANT SCIENCES LTD 3.2%
Value $59.24M Shares 6,545,642 Share Price $9.05 Est. Cost/Share $12.18 Unrealized @ Report Date —
CRNX CRINETICS PHARMACEUTICALS INC 2.5%
Value $46.88M Shares 1,875,209 Share Price $25.00 Est. Cost/Share $29.55 Unrealized @ Report Date -16.2%
RYTM RHYTHM PHARMACEUTICALS INC 2.2%
Value $41.47M Shares 1,884,782 Share Price $22.00 * Est. Cost/Share $28.23 Unrealized @ Report Date -10.6%
— DICERNA PHARMACEUTICALS INC 2.1%
Value $38.69M Shares 2,456,669 Share Price $15.75 Est. Cost/Share $18.43 Unrealized @ Report Date —
ARVN ARVINAS INC 2.0%
Value $37.13M Shares 1,688,412 Share Price $21.99 * Est. Cost/Share $16.46 Unrealized @ Report Date +27.7%
— PREVAIL THERAPEUTICS INC 1.9%
Value $36.22M Shares 2,743,625 Share Price $13.20 Est. Cost/Share $13.20 Unrealized @ Report Date —
AXSM AXSOME THERAPEUTICS INC 1.9%
Value $34.53M Shares 1,340,828 Share Price $25.75 * Est. Cost/Share $9.29 Unrealized @ Report Date +115.9%
STOK STOKE THERAPEUTICS INC 1.8%
Value $32.67M Shares 1,119,963 Share Price $29.17 * Est. Cost/Share $26.85 Unrealized @ Report Date 0.0%
— KALA PHARMACEUTICALS INC 1.6%
Value $28.95M Shares 4,537,478 Share Price $6.38 Est. Cost/Share $13.25 Unrealized @ Report Date —
— SHOCKWAVE MED INC 1.5%
Value $28.29M Shares 495,608 Share Price $57.09 Est. Cost/Share $33.47 Unrealized @ Report Date —
— PRECISION BIOSCIENCES INC 1.3%
Value $24.41M Shares 1,842,366 Share Price $13.25 Est. Cost/Share $17.95 Unrealized @ Report Date —
— SOLID BIOSCIENCES INC 1.1%
Value $21.29M Shares 2,689,444 Share Price $7.92 Est. Cost/Share $7.50 Unrealized @ Report Date —
ALEC ALECTOR INC 1.0%
Value $19M Shares 1,000,000 Share Price $19.00 * Est. Cost/Share $18.92 Unrealized @ Report Date +7.3%
— G1 THERAPEUTICS INC 0.8%
Value $14.84M Shares 483,990 Share Price $30.66 Est. Cost/Share $20.11 Unrealized @ Report Date —
— X4 PHARMACEUTICALS INC 0.7%
Value $12.92M Shares 861,393 Share Price $15.00 Est. Cost/Share $15.00 Unrealized @ Report Date —
— SCPHARMACEUTICALS INC 0.6%
Value $10.36M Shares 3,247,005 Share Price $3.19 Est. Cost/Share $11.02 Unrealized @ Report Date —
— ODONATE THERAPEUTICS INC 0.4%
Value $7.338M Shares 200,000 Share Price $36.69 Est. Cost/Share $36.69 Unrealized @ Report Date —